F2 |
F2: Prothrombin precursor |
FGB |
FGB: Fibrinogen beta chain precursor [Contains: Fibrinopeptide B] |
89.920 |
Evidence |
|
F9 |
F9: Coagulation factor IX precursor |
FGA |
IPI00021885 |
89.920 |
Evidence |
|
ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
89.390 |
Evidence |
|
KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
SLA |
SLA, SLAP, SLAP1: SRC-like-adapter |
89.390 |
Evidence |
|
INSR |
INSR: Insulin receptor precursor |
BLNK |
BLNK, BASH, SLP65: B-cell linker protein |
89.390 |
Evidence |
|
KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
89.390 |
Evidence |
|
FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
89.390 |
Evidence |
|
CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
BMX |
IPI00514142 |
89.390 |
Evidence |
|
SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
89.390 |
Evidence |
|
KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
89.390 |
Evidence |
|
AXL |
AXL, UFO: Tyrosine-protein kinase receptor UFO precursor |
CSK |
CSK: Tyrosine-protein kinase CSK |
89.240 |
Evidence |
|
RET |
RET: Proto-oncogene tyrosine-protein kinase receptor ret precursor |
BMX |
IPI00514142 |
89.240 |
Evidence |
|
ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
RET |
RET: Proto-oncogene tyrosine-protein kinase receptor ret precursor |
89.240 |
Evidence |
|
SERPINF1 |
SERPINF1, PEDF: Pigment epithelium-derived factor precursor |
TMPRSS9 |
IPI00337305 |
89.240 |
Evidence |
|
FGFR1 |
FGFR1, FGFBR, FLG, FLT2: Basic fibroblast growth factor receptor 1 precursor |
SYK |
SYK: Tyrosine-protein kinase SYK |
89.240 |
Evidence |
|
EGFR |
EGFR, ERBB1: Epidermal growth factor receptor precursor |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
89.240 |
Evidence |
|
TEK |
TEK, TIE2: Angiopoietin-1 receptor precursor |
STAT3 |
|
89.240 |
Evidence |
|
AXL |
AXL, UFO: Tyrosine-protein kinase receptor UFO precursor |
SYK |
SYK: Tyrosine-protein kinase SYK |
89.240 |
Evidence |
|
MET |
MET: Hepatocyte growth factor receptor precursor |
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
89.240 |
Evidence |
|
ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
AXL |
AXL, UFO: Tyrosine-protein kinase receptor UFO precursor |
89.240 |
Evidence |
|
STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
89.240 |
Evidence |
|
VAV1 |
VAV1, VAV: Proto-oncogene vav |
AXL |
AXL, UFO: Tyrosine-protein kinase receptor UFO precursor |
89.240 |
Evidence |
|
EGFR |
EGFR, ERBB1: Epidermal growth factor receptor precursor |
LYN |
LYN: Tyrosine-protein kinase Lyn |
89.240 |
Evidence |
|
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
89.240 |
Evidence |
O
|
AXL |
AXL, UFO: Tyrosine-protein kinase receptor UFO precursor |
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
89.240 |
Evidence |
|